Figure 3

Incidence of all-cause mortality by group. (A) In the entire study population. (B) In patients with low-probability of significant fibrosis (FIB-4 < 1.45). (C) In patients with intermediate-probability of significant fibrosis (FIB-4 1.45–3.25). (D) In patients with high-probability of significant fibrosis (FIB-4 ≥ 3.25).